h-phe-gln-val-val-cys(npys)-gly-nh2 structure
|
Common Name | h-phe-gln-val-val-cys(npys)-gly-nh2 | ||
---|---|---|---|---|
CAS Number | 128102-74-9 | Molecular Weight | 772.87200 | |
Density | 1.38g/cm3 | Boiling Point | 1152.3ºC at 760mmHg | |
Molecular Formula | C34H48N10O9S | Melting Point | N/A | |
MSDS | USA | Flash Point | 650.7ºC |
Name | h-phe-gln-val-val-cys(npys)-gly-nh2 |
---|
Density | 1.38g/cm3 |
---|---|
Boiling Point | 1152.3ºC at 760mmHg |
Molecular Formula | C34H48N10O9S |
Molecular Weight | 772.87200 |
Flash Point | 650.7ºC |
Exact Mass | 772.33300 |
PSA | 341.71000 |
LogP | 3.34870 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.63 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
Pept. Res. 7 , 32-35, (1994) Thrombin-induced platelet aggregation has been suggested to play an important role in reocclusion following thrombolytic therapy or angioplasty for treatment of myocardial infarction. We previously de... |
|
Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Eur. J. Biochem. 214 , 233-241, (1993) Thrombin-induced platelet aggregation has been suggested to play an important role in reocclusion following thrombolytic therapy of angioplasty for treatment of myocardial infarction. We previously de... |
|
Specificity of the sequence in Phe-Gln-Val-Val-Cys (-3-nitro-2-pyridinesulfenyl)-Gly-NH2--a selective inhibitor of thrombin-induced platelet aggregation.
Thromb. Res. 72 , 183, (1993) Thrombin-induced platelet aggregation is mediated in part by the intracellularly activated calpain expressed onto the external side of the membrane. We have previously shown that P1, Phe-Gln-Val-Val-C... |